Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 1
1950 1
1951 2
1952 1
1953 5
1954 3
1955 2
1956 2
1957 5
1958 3
1959 7
1960 6
1961 1
1962 13
1963 11
1964 17
1965 17
1966 4
1967 10
1968 8
1969 11
1970 9
1971 8
1972 10
1973 4
1974 6
1975 14
1976 7
1977 18
1978 13
1979 17
1980 11
1981 15
1982 16
1983 11
1984 20
1985 36
1986 45
1987 48
1988 70
1989 73
1990 70
1991 79
1992 90
1993 95
1994 111
1995 120
1996 146
1997 148
1998 175
1999 189
2000 216
2001 224
2002 270
2003 299
2004 387
2005 478
2006 552
2007 607
2008 682
2009 801
2010 950
2011 1081
2012 1157
2013 1355
2014 1422
2015 1381
2016 1470
2017 1534
2018 1688
2019 1837
2020 1982
2021 2185
2022 2441
2023 2252
2024 660

Text availability

Article attribute

Article type

Publication date

Search Results

26,464 results

Results by year

Filters applied: . Clear all
Page 1
Roles and mechanisms of optineurin in bone metabolism.
Jin J, Huang R, Chang Y, Yi X. Jin J, et al. Among authors: chang y. Biomed Pharmacother. 2024 Mar;172:116258. doi: 10.1016/j.biopha.2024.116258. Epub 2024 Feb 12. Biomed Pharmacother. 2024. PMID: 38350370 Free article. Review.
Transcription Factors Leave Their Mark on the Heart.
Chang Y, Francois M, Bagnall RD. Chang Y, et al. Circ Genom Precis Med. 2024 Mar 18:e004598. doi: 10.1161/CIRCGEN.124.004598. Online ahead of print. Circ Genom Precis Med. 2024. PMID: 38497209 No abstract available.
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma.
Casillo SM, Gatesman TA, Chilukuri A, Varadharajan S, Johnson BJ, David Premkumar DR, Jane EP, Plute TJ, Koncar RF, Stanton AJ, Biagi-Junior CAO, Barber CS, Halbert ME, Golbourn BJ, Halligan K, Cruz AF, Mansi NM, Cheney A, Mullett SJ, Land CV, Perez JL, Myers MI, Agrawal N, Michel JJ, Chang YF, Vaske OM, MichaelRaj A, Lieberman FS, Felker J, Shiva S, Bertrand KC, Amankulor N, Hadjipanayis CG, Abdullah KG, Zinn PO, Friedlander RM, Abel TJ, Nazarian J, Venneti S, Filbin MG, Gelhaus SL, Mack SC, Pollack IF, Agnihotri S. Casillo SM, et al. Among authors: chang yf. Cell Rep. 2024 Jan 23;43(1):113557. doi: 10.1016/j.celrep.2023.113557. Epub 2023 Dec 18. Cell Rep. 2024. PMID: 38113141 Free article.
Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.
Huang L, Pang D, Yang H, Li W, Wang S, Cui S, Liao N, Wang Y, Wang C, Chang YC, Wang HC, Kang SY, Seo JH, Shen K, Laohawiriyakamol S, Jiang Z, Wang H, Lamour F, Song G, Curran M, Duan C, Lysbet de Haas S, Restuccia E, Shao Z. Huang L, et al. Among authors: chang yc. Nat Commun. 2024 Mar 9;15(1):2153. doi: 10.1038/s41467-024-45591-7. Nat Commun. 2024. PMID: 38461323 Free PMC article. Clinical Trial.
26,464 results
You have reached the last available page of results. Please see the User Guide for more information.